kaonavi
4435
D. Western Therapeutics Institute
4576
Itamiarts
168A
Nakayo
6715
Allied Telesis Holdings KK
6835
(Q3)Dec 31, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 1.64%13B | 10.28%52.09B | -0.81%14.11B | 6.70%12.79B | 19.95%12.76B | 19.71%12.43B | 28.37%47.24B | 30.96%14.23B | 17.63%11.99B | 31.76%10.64B |
Cost of revenue | 0.62%6.48B | 9.25%26.23B | -1.80%7.14B | 6.41%6.44B | 18.89%6.45B | 17.88%6.21B | 25.90%24.01B | 29.08%7.27B | 13.66%6.05B | 29.43%5.42B |
Gross profit | 2.67%6.52B | 11.34%25.86B | 0.23%6.97B | 6.99%6.35B | 21.05%6.32B | 21.59%6.22B | 31.02%23.22B | 32.99%6.95B | 21.96%5.94B | 34.28%5.22B |
Operating expense | 1.34%5.55B | 6.53%22.1B | -0.62%5.82B | 7.86%5.48B | 10.20%5.41B | 10.02%5.39B | 11.33%20.74B | 19.21%5.86B | 6.59%5.08B | 7.46%4.91B |
Operating profit | 11.02%971.94M | 51.53%3.76B | 4.78%1.15B | 1.86%875.47M | 192.49%908.48M | 282.02%831.44M | 374.95%2.48B | 247.45%1.1B | 724.84%859.5M | 145.62%310.61M |
Net non-operating interest income (expenses) | -5.65%14.63M | 22.10%58.74M | 23.97%15.05M | 28.91%15.51M | 15.91%14.31M | 19.67%13.89M | 7.88%48.11M | 10.35%12.14M | 13.14%12.03M | 8.72%12.34M |
Non-operating interest income | 0.00%20.52M | 0.28%81.79M | 1.14%20.07M | 0.00%20.52M | 0.00%20.85M | 0.00%20.34M | 0.02%81.56M | 0.03%19.85M | 0.00%20.52M | 0.04%20.85M |
Non-operating interest expense | 17.46%5.89M | -31.11%23.04M | -34.79%5.03M | -40.92%5.02M | -23.07%6.55M | -26.15%6.45M | -9.47%33.45M | -12.80%7.71M | -14.12%8.49M | -10.34%8.51M |
Net investment income | -72.83%501K | 30.51%3.47M | 0 | 47.40%1.84M | 3.54%1.41M | 340.00%220K | 24.61%2.66M | 0 | 154.27%1.25M | -0.22%1.36M |
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
Income from associates and other participating interests | ||||||||||
Special income (charges) | -219.40%-82.88M | -20.24%-289.29M | 18.87%-177.62M | -32.20%-25.95M | -62.89%-54.05M | -201.71%-31.68M | 47.33%-240.6M | -101.74%-218.94M | -157.81%-19.63M | 78.34%-33.18M |
Less:Other special charges | 1,445.29%73.97M | 314.38%63.24M | 55.08%-3.44M | 0.99%4.79M | 204.59%47.14M | 135.07%14.75M | -109.74%-29.5M | 42.16%-7.66M | 113.84%4.74M | -87.38%15.48M |
Less:Write off | -57.92%8.91M | -16.30%226.06M | -20.10%181.06M | 42.13%21.16M | -61.00%6.9M | 55.31%16.93M | 75.50%270.09M | 86.08%226.6M | 4,797.37%14.89M | -42.00%17.7M |
Other non-operating income (expenses) | 158.18%8.61M | -59.86%21.93M | -79.82%6.78M | -8.21%3.33M | -22.48%9.3M | -53.42%2.51M | -30.81%54.64M | 135.67%33.61M | -86.11%3.63M | -49.55%12M |
Income before tax | 4.90%912.8M | 51.51%3.56B | 7.56%993.05M | 1.57%870.2M | 190.13%879.44M | 207.09%816.37M | 290.27%2.35B | 297.44%923.27M | 388.43%856.79M | 138.01%303.13M |
Income tax | 5.08%338.21M | 1.34%1.07B | -60.07%204.88M | 0.91%321.86M | 125.30%246.72M | 156.73%298.58M | 405.31%1.06B | 357.53%513.1M | 288.77%318.96M | 141.77%109.51M |
Net income | 4.79%574.59M | 92.62%2.49B | 92.15%788.16M | 1.95%548.34M | 226.79%632.72M | 246.26%517.8M | 245.38%1.29B | 241.36%410.18M | 476.01%537.83M | 136.16%193.62M |
Net income continuous operations | 4.79%574.59M | 92.62%2.49B | 92.15%788.16M | 1.95%548.34M | 226.79%632.72M | 246.26%517.8M | 245.38%1.29B | 241.36%410.18M | 476.00%537.83M | 136.16%193.62M |
Noncontrolling interests | ||||||||||
Net income attributable to the company | 4.79%574.59M | 92.62%2.49B | 92.15%788.16M | 1.95%548.34M | 226.79%632.72M | 246.26%517.8M | 245.38%1.29B | 241.36%410.18M | 476.01%537.83M | 136.16%193.62M |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | 4.79%574.59M | 92.62%2.49B | 92.15%788.16M | 1.95%548.34M | 226.79%632.72M | 246.26%517.8M | 245.38%1.29B | 241.36%410.18M | 476.01%537.83M | 136.16%193.62M |
Gross dividend payment | ||||||||||
Basic earnings per share | 4.77%19.77 | 92.60%85.59 | 92.07%27.12 | 1.94%18.87 | 227.03%21.78 | 246.02%17.82 | 245.42%44.44 | 241.06%14.12 | 476.64%18.51 | 136.16%6.66 |
Diluted earnings per share | 4.77%19.77 | 92.60%85.59 | 92.11%27.12 | 1.95%18.87 | 226.96%21.7756 | 246.02%17.82 | 245.42%44.44 | 241.36%14.1166 | 476.63%18.5098 | 136.15%6.66 |
Dividend per share | 0 | 33.33%30 | 33.33%30 | 0 | 0 | 0 | 50.00%22.5 | 50.00%22.5 | 0 | 0 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |